好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | S26 - Neuro-opthalmology/Neuro-otology

Tuesday 04/25/17
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Neuro-ophthalmology/Neuro-otology
2.00 CME credits
Event Timeline
03:30 PM - 05:30 PM Abstract 001 - Overdiagnosis of optic neuritis.
Leanne Stunkel, MD
03:30 PM - 05:30 PM Abstract 002 - Sensory prosthetics - clinical and scientific utility of a vestibular implant
03:30 PM - 05:30 PM Abstract 003 - Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the Nationwide Inpatient Sample 1998-2013
Heather Moss, MD, PhD, FAAN
03:30 PM - 05:30 PM Abstract 004 - Gene Therapy for LHON : Low and Medium Dose Results
John R. Guy, MD
03:30 PM - 05:30 PM Abstract 005 - Intravitreal rAAV2/2-ND4 (GS010): A gene therapy for vision loss in Leber′s Hereditary Optic Neuropathy (LHON) caused by the G11778A ND4 mitochondrial mutation
Scott Uretsky, MD
03:30 PM - 05:30 PM Abstract 006 - Jun and Ddit3 (CHOP) deficiency provides additive protection for retinal ganglion cell death after optic nerve injury
Stephanie Syc-Mazurek, MD, PhD
03:30 PM - 05:30 PM Abstract 007 - Does the Combination of Acute Hearing Loss and Vertigo Increase Stroke Risk?
Tzu-Pu Chang
03:30 PM - 05:30 PM Abstract 008 - Visual Fixation Instability for Evaluating Multiple Sclerosis Using OCT-Based Quantification of Retinal Movements
Robert Mallery, MD
05:10 PM - 05:30 PM Speaker Discussion
Gregory P. Van Stavern, MD, FAAN
Faculty Disclosures
Gregory P. Van Stavern, MD, FAAN Dr. Van Stavern has received publishing royalties from a publication relating to health care.
Eric R. Eggenberger, DO, FAAN Dr. Eggenberger has nothing to disclose.
Christopher C. Glisson, DO, FAAN Dr. Glisson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Glisson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for argenx.
No disclosure on file
Matthew J. Thurtell, MD Dr. Thurtell has received publishing royalties from a publication relating to health care.
Scott Uretsky, MD No disclosure on file
Victor C. Urrutia, MD Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Director of CME course with PeerView.
David E. Newman-Toker, MD, PhD, FAAN The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Tzu-Pu Chang No disclosure on file
Jose-Alain Sahel The institution of Jose-Alain Sahel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avista. The institution of Jose-Alain Sahel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tenpoint . The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF GENSIGHT. The institution of Jose-Alain Sahel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for THE BOARD OF SPARINGVISION. Jose-Alain Sahel has stock in Prophesee. Jose-Alain Sahel has stock in Tilak Healthcare. Jose-Alain Sahel has stock in Sparing Vision. Jose-Alain Sahel has stock in Chronolife. Jose-Alain Sahel has stock in VegaVect Inc.. Jose-Alain Sahel has stock in Avista. Jose-Alain Sahel has stock in Tenpoint. Jose-Alain Sahel has stock in SharpEye. Jose-Alain Sahel has stock in GenSight. The institution of Jose-Alain Sahel has received research support from LabEx LIFESENSES (ANR-10-LABX-65). The institution of Jose-Alain Sahel has received research support from IHU FOReSIGHT (ANR-18-IAHU-01). The institution of Jose-Alain Sahel has received research support from ERC Synergy "HELMHOLTZ". Jose-Alain Sahel has received intellectual property interests from a discovery or technology relating to health care.
Ariel A. Winnick, MD, MA No disclosure on file
Robert Mallery, MD Dr. Mallery has nothing to disclose.
Stephanie Syc-Mazurek, MD, PhD Dr. Syc-Mazurek has a non-compensated relationship as a Editorial Board Resident and Fellows Section with Neurology that is relevant to AAN interests or activities.
Teresa Frohman, PA No disclosure on file
Heather Moss, MD, PhD, FAAN Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Twenty Twenty Therapeutics. Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Inc. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Department of Defense. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with NASA. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Leanne Stunkel, MD Dr. Stunkel has nothing to disclose.
Byron Lam, MD No disclosure on file
John R. Guy, MD No disclosure on file
Rajeshwari D. Koilkonda No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Nathan Kung, MD No disclosure on file